Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
0.7544 USD | -6.34% | -4.24% | -0.28% |
Kurzporträt
Mitarbeiterzahl: 22
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Leonard Mazur
CEO | Chief Executive Officer | 79 | 01.07.13 |
Jaime Bartushak
DFI | Director of Finance/CFO | 57 | 27.11.17 |
Preeti Singh
CTO | Chief Tech/Sci/R&D Officer | - | 01.01.22 |
Myron Czuczman
CTO | Chief Tech/Sci/R&D Officer | 65 | 14.07.20 |
Alan Lader
CTO | Chief Tech/Sci/R&D Officer | - | 01.03.16 |
Gary Talarico
COO | Chief Operating Officer | 69 | 01.03.16 |
Myron Holubiak
BRD | Director/Board Member | 77 | 01.10.15 |
Ilanit Allen
IRC | Investor Relations Contact | - | 17.05.21 |
General Counsel | - | 10.02.22 | |
Paul Sowyrda
PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Myron Holubiak
BRD | Director/Board Member | 77 | 01.10.15 |
Dennis McGrath
BRD | Director/Board Member | 67 | 07.02.23 |
Leonard Mazur
CEO | Chief Executive Officer | 79 | 01.07.13 |
Carol Webb
BRD | Director/Board Member | 78 | 01.03.16 |
Suren Dutia
BRD | Director/Board Member | 82 | 01.10.15 |
Eugene Holuka
BRD | Director/Board Member | 65 | 01.06.16 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 159 094 781 | 146 786 842 ( 92,26 %) | 0 | 92,26 % |
Unternehmenskontakt
Citius Pharmaceuticals, Inc.
11 Commerce Drive 1st floor
07016, Cranford
+908 967 6677
http://www.citiuspharma.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-0.28% | 128 Mio. | |
-1.42% | 41.35 Mrd. | |
+42.15% | 40.38 Mrd. | |
+1.97% | 39.05 Mrd. | |
-14.19% | 26.67 Mrd. | |
+1.82% | 24.07 Mrd. | |
-24.55% | 18.36 Mrd. | |
-4.07% | 11.68 Mrd. | |
+21.36% | 11.6 Mrd. | |
+8.20% | 11.15 Mrd. |
- Börse
- Aktien
- A2DXS0 Aktie
- Unternehmen Citius Pharmaceuticals, Inc.